AG真人官方

Form 4 overview: UnitedHealth Group Inc. (UNH) reported one insider transaction by Patrick H. Conway, Chief Executive Officer of Optum. On 24 June 2025, Conway acquired 73.058 shares of common stock at a stated price of $0.00. The shares represent dividend equivalents that accrue on previously granted restricted stock units (RSUs); they will vest or be forfeited under the same conditions as the underlying RSUs.

Following the credit, Conway鈥檚 total beneficial ownership increased to 10,471.511 shares, held in direct form. No derivative securities were reported in this filing, and there were no dispositions or sales.

Key points for investors:

• The transaction is non-open-market and mechanically linked to existing RSUs, signalling neither an active purchase nor a sale decision.
• The share increase is immaterial鈥攁bout 0.7% of Conway鈥檚 reported holdings and negligible relative to UnitedHealth鈥檚 ~930 million shares outstanding.
• No Rule 10b5-1 trading plan was indicated, and there are no signs of strategic shifts, financing activities, or performance commentary in the filing.

Overall, the Form 4 reflects routine compensation-related activity with neutral implications for UnitedHealth shareholders.

Form 4 filing overview for UnitedHealth Group Inc. (UNH)

Chief Accounting Officer Thomas E. Roos reported a small automatic acquisition of company stock on 24 June 2025. The filing discloses the crediting of 25.252 dividend-equivalent shares tied to previously granted restricted stock units (RSUs). These shares were received at $0 cost, consistent with the dividend-equivalent feature of the RSUs. Following the transaction, Roos鈥� direct beneficial ownership increased to 29,524.318 common shares.

No derivative securities were acquired or disposed of, and there were no open-market purchases or sales. The transaction code 鈥淎鈥� confirms it was an acquisition rather than a sale, and the explanation section clarifies that the shares will forfeit if the underlying RSUs fail to vest.

Investor takeaway: The filing reflects routine dividend-equivalent accretion and signals continued alignment of the senior officer鈥檚 compensation with shareholder returns, but the volume (<1% of the insider鈥檚 holdings) is immaterial to UNH鈥檚 share float and is unlikely to influence market sentiment.

Transaction details: On 24 June 2025 UnitedHealth Group Inc. (UNH) director Michele J. Hooper received 266 shares of UNH common stock, as disclosed in a Form 4 filed with the SEC on 26 June 2025. The shares were credited as dividend equivalents on previously vested deferred stock units (DSUs); accordingly, no cash consideration was paid (transaction price reported as $0) and no open-market trade occurred.

Post-transaction ownership: Following the award, Ms. Hooper's direct ownership increased to 40,306 shares. No derivative securities were acquired or disposed, and there were no sales. The filing indicates direct ownership (box "D") and does not reference a Rule 10b5-1 trading plan.

Investor context: A 266-share increment represents less than 1% of Ms. Hooper's holdings and is immaterial relative to UnitedHealth's roughly 930 million outstanding shares. Such dividend-equivalent accruals are routine for deferred equity awards and generally signal neither bullish nor bearish sentiment. The filing does, however, reaffirm the director's continuing equity alignment with shareholders.

Insider activity: On 24 Jun 2025, UnitedHealth Group (UNH) director and former CEO Stephen J. Hemsley reported the credit of 55 common shares at $0 cost, reflecting dividend-equivalent units paid on previously vested deferred stock units. These shares were immediately vested and subject to the same terms as the underlying units. Following the credit, Hemsley鈥檚 direct holdings rose to roughly 374,407.942 shares, alongside 347.29 shares held through a 401(k) plan and 735,115 shares held via family trusts. No derivative securities were exercised, and the filing does not reference a Rule 10b5-1 trading plan. The adjustment is routine, immaterial relative to Hemsley鈥檚 more than 1.1 million-share beneficial stake, and is unlikely to influence market perception or valuation.

On June 26, 2025, UnitedHealth Group Incorporated (UNH) filed a Form 4 disclosing that director Kristen L. Gil acquired 7 shares of common stock on June 24, 2025. The acquisition was coded "A" and carried a price of $0 per share because the shares represent dividend equivalents paid on vested deferred stock units.

Following the transaction, Gil directly owns 1,558 shares and indirectly holds 3,800 shares through a trust. No derivative securities were reported. The transaction is routine and immaterial to UnitedHealth's float but modestly increases insider alignment with shareholders.